Vor Bio to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Aug 28, 2024
CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:
Read more at globenewswire.com
